Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $32.9100 (-0.36%) ($30.3000 - $33.8300) on Fri. Feb. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.61% (three month average) | RSI | 87 | Latest Price | $32.9100(-0.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 4.7% a day on average for past five trading days. | Weekly Trend | IOVA advances 16.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(44%) ARKK(43%) | Factors Impacting IOVA price | IOVA will decline at least -2.305% in a week (0% probabilities). VIXM(-28%) VXX(-16%) UUP(-10%) TLT(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.305% (StdDev 4.61%) | Hourly BBV | 0 () | Intraday Trend | 6.2% | | | |
|
5 Day Moving Average | $31.15(5.65%) | 10 Day Moving Average | $28.17(16.83%) | 20 Day Moving Average | $25.76(27.76%) | To recent high | -2.2% | To recent low | 52.1% | Market Cap | $4.819b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |